The present invention relates to compositions and methods for the delivery of therapeutic proteins to the CNS using recombinant AAV 10 vectors. More specifically, the invention relates to compositions and methods for delivering proteins into the cerebrospinal fluid of mammalian subjects through peripheral administration of AAV10 vectors. The invention may be used to treat various disorders of the central nervous system, including degenerative diseases and motor neuron diseases.